Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-26

Clinical Trial Update: Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fixed combination bimatoprost/timolol to latanoprost in treatment-naïve open-angle glaucoma patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)
  • bimatoprost/timolol fixed combination (bimatoprost/timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle | Phase 4 | Status: COMPLETED | Results posted: 2013-02-26